Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast

Journal of Clinical Pathology - Molecular Pathology

Volumn 53, Issue 3, 2000, Pages 118-121

  Buerger, H ^a   Simon, R ^a   Schafer K L ^a   Diallo, R ^a   Littmann, R ^a   Poremba, C ^a   Van Diest, P J ^b   Dockhorn Dworniczak, B ^a   Bocker W ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Ductal carcinoma in situ; Invasion; Lobular carcinoma in situ

Indexed keywords

UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER INVASION; CARCINOMA IN SITU; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL DIFFERENTIATION; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM INVASIVENESS;

EID: 0034121291     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.53.3.118     Document Type: Article

References (16)

1. 1 Teixeira MR, Pandis N, Bardi G, et al. Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int J Cancer 1995;63:63-8.
2. 2 Buerger H, Otterbach F, Simon R, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 1999;187:396-402.
3. 3 Kuukasjarvi T, Tanner M, Pennanen S, et al. Generic changes in intraductal breast cancer detected by comparative genomic hybridization. Am J Pathol 1997;150:1465-71.
4. 4 Lu YJ, Osin P, Lakhani SR, et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998;58:4721-7.
5. 5 Millikan R, Dressler L, Geradts J, et al. The need for epidemiologic studies of in-situ carcinoma of the breast. Breast Cancer Res Treat 1995;35:65-77.
6. 6 Bankfalvi A, Terpe H-J, Breukelmann D, et al. Immunophenotypic and prognostic analysis of E-cadherin (E-Cad) and β-Catenin (β-Cat) expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology 1999;34:25-34.
7. 7 Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80.
8. 8 Ellis IO, Elston CW. Tumours of the breast. In: Fletcher CDM, ed. Diagnostic histopathology of tumours. Edinburgh: Churchill Livingstone, 1998:635-89.
9. 9 Tavassoli FA. Pathology of the breast. Norwalk, Conneticut: Appleton and Lange, 1992.
10. 10 Silverstein MJ, Poller DM, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7.
11. 11 Nishizaki T, Chew K, Chu L, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997;74:513-17.
12. 12 Buerger H, Otterbach F, Simon R, et al. Different generic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999;189:521-6.
13. 13 Shackney SE, Shankey TV. Common patterns of genetic evolution in human solid tumors. Cytometry 1997;29:1-27.
14. 14 Chuaqui RF, Zhuang Z, Emmert BM, et al. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 1997;150:297-303.
15. 15 Nayar R, Zhuang Z, Merino MJ, et al. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 1997;28:277-82.
16. 16 Fujii H, Marsh C, Cairns P, et al. Genetic divergence in the clonal evolution of breast cancer. Cancer Res 1996;56: 1493-7.